/
HKPD
$0.36-$0.00 (-0.28%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$8.5M
23M shares
52-week range
$0.32 – $2.58
2% from low
Exchange
NASDAQ
CS
Borrow rate
5.23%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-2.46
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
www.9zt.hk- Employees
- 27
- IPO / List date
- Jan 15, 2025
Held by traders on TradeandTell
No one on the platform currently holds HKPD.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HKPD as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded HKPD yet.
